BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 21431697)

  • 1. Aptamer-targeted RNAi for HIV-1 therapy.
    Zhou J; Rossi JJ
    Methods Mol Biol; 2011; 721():355-71. PubMed ID: 21431697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel dual inhibitory function aptamer-siRNA delivery system for HIV-1 therapy.
    Zhou J; Li H; Li S; Zaia J; Rossi JJ
    Mol Ther; 2008 Aug; 16(8):1481-9. PubMed ID: 18461053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual functional RNA nanoparticles containing phi29 motor pRNA and anti-gp120 aptamer for cell-type specific delivery and HIV-1 inhibition.
    Zhou J; Shu Y; Guo P; Smith DD; Rossi JJ
    Methods; 2011 Jun; 54(2):284-94. PubMed ID: 21256218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of cell-type specific anti-HIV gp120 aptamers for siRNA delivery.
    Zhou J; Li H; Zhang J; Piotr S; Rossi J
    J Vis Exp; 2011 Jun; (52):. PubMed ID: 21730942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selection, characterization and application of new RNA HIV gp 120 aptamers for facile delivery of Dicer substrate siRNAs into HIV infected cells.
    Zhou J; Swiderski P; Li H; Zhang J; Neff CP; Akkina R; Rossi JJ
    Nucleic Acids Res; 2009 May; 37(9):3094-109. PubMed ID: 19304999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor-targeted aptamer-siRNA conjugate-directed transcriptional regulation of HIV-1.
    Zhou J; Lazar D; Li H; Xia X; Satheesan S; Charlins P; O'Mealy D; Akkina R; Saayman S; Weinberg MS; Rossi JJ; Morris KV
    Theranostics; 2018; 8(6):1575-1590. PubMed ID: 29556342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional in vivo delivery of multiplexed anti-HIV-1 siRNAs via a chemically synthesized aptamer with a sticky bridge.
    Zhou J; Neff CP; Swiderski P; Li H; Smith DD; Aboellail T; Remling-Mulder L; Akkina R; Rossi JJ
    Mol Ther; 2013 Jan; 21(1):192-200. PubMed ID: 23164935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-type-specific aptamer and aptamer-small interfering RNA conjugates for targeted human immunodeficiency virus type 1 therapy.
    Zhou J; Rossi J
    J Investig Med; 2014 Oct; 62(7):914-9. PubMed ID: 25118114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methods for assembling B-cell lymphoma specific and internalizing aptamer-siRNA nanoparticles via the sticky bridge.
    Zhou J; Rossi JJ; Shum KT
    Methods Mol Biol; 2015; 1297():169-85. PubMed ID: 25896003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific HIV-1 env gene silencing by small interfering RNAs in human peripheral blood mononuclear cells.
    Park WS; Hayafune M; Miyano-Kurosaki N; Takaku H
    Gene Ther; 2003 Nov; 10(24):2046-50. PubMed ID: 14566364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic potential of aptamer-siRNA conjugates for treatment of HIV-1.
    Zhou J; Rossi JJ
    BioDrugs; 2012 Dec; 26(6):393-400. PubMed ID: 23046156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of HIV-1 protease expression in T cells owing to DNA aptamer-mediated specific delivery of siRNA.
    Zhu Q; Shibata T; Kabashima T; Kai M
    Eur J Med Chem; 2012 Oct; 56():396-9. PubMed ID: 22907035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incorporation of aptamers in the terminal loop of shRNAs yields an effective and novel combinatorial targeting strategy.
    Pang KM; Castanotto D; Li H; Scherer L; Rossi JJ
    Nucleic Acids Res; 2018 Jan; 46(1):e6. PubMed ID: 29077949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Advance in the study of targeting delivery system for siRNA mediated by aptamers].
    Wang XL; Wang QQ; Song HF
    Yao Xue Xue Bao; 2012 Jul; 47(7):850-5. PubMed ID: 22993847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of human immunodeficiency virus type 1 replication by siRNA targeted to the highly conserved primer binding site.
    Han W; Wind-Rotolo M; Kirkman RL; Morrow CD
    Virology; 2004 Dec; 330(1):221-32. PubMed ID: 15527848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aptamer-siRNA chimeras for HIV.
    Takahashi M; Burnett JC; Rossi JJ
    Adv Exp Med Biol; 2015; 848():211-34. PubMed ID: 25757623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular siRNA delivery mediated by a cell-permeant RNA-binding protein and photoinduced RNA interference.
    Endoh T; Sisido M; Ohtsuki T
    Bioconjug Chem; 2008 May; 19(5):1017-24. PubMed ID: 18442282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small interfering RNAs against the TAR RNA binding protein, TRBP, a Dicer cofactor, inhibit human immunodeficiency virus type 1 long terminal repeat expression and viral production.
    Christensen HS; Daher A; Soye KJ; Frankel LB; Alexander MR; Lainé S; Bannwarth S; Ong CL; Chung SW; Campbell SM; Purcell DF; Gatignol A
    J Virol; 2007 May; 81(10):5121-31. PubMed ID: 17360756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An aptamer-siRNA chimera suppresses HIV-1 viral loads and protects from helper CD4(+) T cell decline in humanized mice.
    Neff CP; Zhou J; Remling L; Kuruvilla J; Zhang J; Li H; Smith DD; Swiderski P; Rossi JJ; Akkina R
    Sci Transl Med; 2011 Jan; 3(66):66ra6. PubMed ID: 21248316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies for siRNA navigation to desired cells.
    Sioud M
    Methods Mol Biol; 2015; 1218():201-16. PubMed ID: 25319653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.